<DOC>
	<DOCNO>NCT02268071</DOCNO>
	<brief_summary>The STOP-Trial prospective multicenter nonrandomized open study grade I hypertension , perform General Practitioners . The main purpose study determine factor associate rate patient remain normotensive one year stop antihypertensive monotherapy low dose dual therapy : - white coat hypertension - primary diagnosis home blood pressure measurement ( HBPM ) /ambulatory blood pressure measurement ( ABPM ) /clinical measure - initial blood pressure level - compliance - therapeutic class versus others - age - gender - weight variation - modification lifestyle - concomitant treatment associate substances The primary endpoint rate normotensive patient one year ( i.e . HBPM value &lt; 135/85 mmHg ) .</brief_summary>
	<brief_title>Stopping Antihypertensive Treatment amOng Hypertensive Patients Primary Care ( STOP-Trial )</brief_title>
	<detailed_description>HBPM perform patient twice day 7 consecutive day visit ( ESH protocol ) , use device clinically test ( ESH/international protocol ) . At baseline ( visit 1 ) , patient include , antihypertensive treatment stop 3 consecutive day ( half dose interruption ) , maximum period 12 month correspond length participation monitoring patient . Follow-up visit day 30 ( visit 2 ) , day 90 ( visit 3 ) , day 180 ( visit 4 ) , day 270 ( visit 5 ) day 360 ( visit 6 ) . Will perform visit : - Calculation average HBPM value investigator - Measurements office blood pressure ( average 3 consecutive measurement ) - SF 36 scale baseline ( visit 1 ) day 360 ( visit 6 ) - During follow-up , investigator free time reintroduce antihypertensive treatment average HBPM value great equal 135/85 mmHg two consecutive visit , great equal 155/95 mmHg regardless visit regardless office blood pressure level . At end study , recovery antihypertensive treatment patient leave discretion investigator .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Tin Fluorides</mesh_term>
	<criteria>Ambulatory patient 18 year old , consult general practitioner . Grade I hypertension diagnosis . Hypertension diagnose treated antihypertensive drug least two year . Controlled hypertension ( Clinical BP &lt; 140/90 mmHg ) uncontrolled hypertension ( Clinical BP &gt; equal 140/90 mmHg ) without modification treatment least 6 month , monotherapy low dose dual therapy . HBPM value &lt; 135/85mmHg ( order exclude mask hypertension ) . Patient sign informed consent form . Patient affiliate national insurance scheme . Personal cardiovascular history and/or necessity take antihypertensive treatment another reason hypertension ( heart failure , migraine , peripheral arterial disease , coronary heart disease , strokeâ€¦ ) . Target organ damage ( evidence ventricular hypertrophy ECG cardiac echography and/or proteinuria and/or pathological microalbuminuria presence show nephropathy , last year ) . Poorly compliant patient , whose score Girerd questionnaire equal great 3 . Existence progressive disease likely impact life expectancy short term . Existence document atrial fibrillation ( contraindication HBPM ) . Patient legal protection measure . Chronic alcohol drug abuse , regular intake vasopressor effect substance ( licorice , cocaine , ... ) . Current known pregnancy project pregnancy within one year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Stopping antihypertensive treatment</keyword>
	<keyword>Primary care</keyword>
	<keyword>White coat hypertension</keyword>
	<keyword>Masked Hypertension</keyword>
</DOC>